Publication | Closed Access

Adjuvant chemotherapy of S-1 versus gemcitabine for resected pancreatic cancer: a phase 3, open-label, randomised, non-inferiority trial (JASPAC 01)

Surgical OncologyOncologyPancreatic CancerGastrointestinal OncologyAdjuvant ChemotherapyJaspac 01Cancer TreatmentMedicineRadiation Oncology